Stockscreener 앱 받기
1.35
0.75%
0.01
시장 영업 전:
1.33
-0.02
-1.48%
전일 마감가:
$1.34
열려 있는:
$1.32
하루 거래량:
1.78M
Relative Volume:
0.63
시가총액:
$67.89M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-0.8659
EPS:
-1.559
순현금흐름:
-
1주 성능:
-1.46%
1개월 성능:
+32.35%
6개월 성능:
+35.72%
1년 성능:
-44.21%
1일 변동 폭
$1.28
$1.38
1주일 범위
$1.28
$1.47
52주 변동 폭
$0.825
$3.481
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
GUTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.35 | 177.14M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-15 | 개시 | H.C. Wainwright | Buy |
| 2025-08-28 | 개시 | Ladenburg Thalmann | Buy |
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Why Fractyl Health Inc. stock attracts global investorsTrend Reversal & Reliable Trade Execution Plans - newser.com
Is Fractyl Health Inc. trending in predictive chart modelsJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
Is Fractyl Health Inc. stock ready for a breakoutJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Fractyl Health Inc.’s volatility index tracking explained2025 Stock Rankings & Consistent Profit Alerts - newser.com
Is Fractyl Health Inc. reversing from oversold territoryJuly 2025 Review & Weekly High Potential Stock Alerts - newser.com
Signal strength of Fractyl Health Inc. stock in tech scanners2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
How institutional buying supports Fractyl Health Inc. stock2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
How Fractyl Health Inc. stock compares to growth peersShort Setup & Real-Time Chart Breakout Alerts - newser.com
Applying sector rotation models to Fractyl Health Inc.Market Growth Review & Weekly Return Optimization Alerts - newser.com
Is Fractyl Health Inc a good long term investmentVolume Weighted Average Price & Small Investment Capital Gains - earlytimes.in
What to expect from Fractyl Health Inc. in the next 30 daysBuy Signal & Momentum Based Trading Ideas - newser.com
Fractyl Health Approves Share Issuance in Special Meeting - MSN
Price momentum metrics for Fractyl Health Inc. explainedWeekly Stock Summary & Consistent Profit Trade Alerts - newser.com
Historical volatility pattern of Fractyl Health Inc. visualizedStop Loss & Weekly Top Gainers Trade List - newser.com
Real time social sentiment graph for Fractyl Health Inc.Quarterly Trade Review & Verified Entry Point Detection - newser.com
Is it time to cut losses on Fractyl Health Inc.July 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Analyzing recovery setups for Fractyl Health Inc. investorsJuly 2025 News Drivers & Verified Swing Trading Watchlist - newser.com
Leading vs lagging indicators on Fractyl Health Inc. performanceDip Buying & Daily Market Momentum Tracking - newser.com
Fractyl Health (NASDAQ:GUTS) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Fractyl Health Inc Stock Analysis and ForecastSell Signals and Alerts & Turn Market Volatility into Wealth - earlytimes.in
Fractyl Health reports preclinical data on RJVA-002 for obesity - BioWorld MedTech
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity - StreetInsider
Promising Potential of Fractyl Health’s Innovative Gene Therapy for Obesity Earns Buy Rating - TipRanks
Fractyl Health, Inc. Announces Potent Preclinical Results from RJVA-002 - MarketScreener
Fractyl’s gene therapy shows 30% weight loss in obesity model By Investing.com - Investing.com Nigeria
Fractyl Health's RJVA-002 Demonstrates ~30% Weight Loss in Preclinical Obesity Model, Highlighting Potential as Next-Generation Therapy - Quiver Quantitative
Fractyl Health Announces Potent Preclinical Results from - GlobeNewswire
~30% Weight Loss in 5 Weeks — Fractyl Health's RJVA-002 Single-Dose Preclinical Gene Therapy - Stock Titan
Is Fractyl Health Inc. showing signs of accumulationDollar Strength & Verified Chart Pattern Trade Signals - newser.com
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Update - MarketBeat
How to escape a deep drawdown in Fractyl Health Inc.GDP Growth & Reliable Momentum Entry Alerts - newser.com
Has Fractyl Health Inc. formed a bullish divergenceEarnings Overview Report & Precise Trade Entry Recommendations - newser.com
What analysts say about Fractyl Health Inc stockChart Pattern Recognition & Fast Profit Trading Strategies - earlytimes.in
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Retail Investors Among Fractyl Health, Inc.'s (NASDAQ:GUTS) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 35% Last Week - 富途牛牛
How to use a screener to detect Fractyl Health Inc. breakoutsBear Alert & Safe Capital Growth Tips - newser.com
How to use Fibonacci retracement on Fractyl Health Inc.Portfolio Gains Report & Proven Capital Preservation Methods - newser.com
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.15%
1.45%
자본화:
|
볼륨(24시간):